Commenting today on the Centers for Medicare & Medicaid Services’ guidance for providers and facilities on the notice-and-consent process for patients choosing to waive their balance billing protections under the No Surprises Act, as well as the public disclosure process to inform patients of these protections, AHA said implementing the provisions present “some logistical and operational challenges for providers,” particularly related to notice-and-consent documents. 

“While we share the objective of ensuring patients have the information they need to make informed decisions about their care, we believe steps must be taken to accomplish this goal without adding unnecessary costs and burdens to the health care system,” AHA wrote.

Specifically, the letter calls on CMS to convene a stakeholder advisory group to review the standard notice and consent forms for implementing balanced billing protections for patients under the No Surprises Act, and the process for sharing the forms with patients and payers. 

AHA plans to submit separate comments on the July 13 interim final rule, “Part 1” of regulations implementing the No Surprises Act.

Headline
The AHA Aug. 28 shared concerns with the Centers for Medicare & Medicaid Services regarding the calendar year 2027 hospital outpatient prospective payment…
Headline
The AHA provided comments to the Centers for Medicare & Medicaid Services Aug. 28 on its calendar year 2027 home health prospective payment system proposed…
Headline
The AHA Aug. 25 submitted comments to Sen. Bill Cassidy, R-La., on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act),…
Headline
The Department of Homeland Security today released a proposed rule to establish a new $103,265 filing fee for H-1B visa petitions that are subject to statutory…
Headline
President Trump announced Aug. 19 that he has nominated Heidi Overton to serve as the next commissioner of the Food and Drug Administration. Overton currently…
Headline
The Centers for Medicare & Medicaid Services Aug. 12 released an advisory for certain clinicians who are qualifying alternative payment model participants…